sj-docx-1-opp-10.1177_10781552221103551 - Supplemental material for Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma

Supplemental material, sj-docx-1-opp-10.1177_10781552221103551 for Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma by Maria-Victoria Mateos, Sophie Rigaudeau, Supratik Basu, Ivan Spicka, Rik Schots, Tomasz Wrobel, Gordon Cook, Meral Beksac, Katharine S Gries, Anupa Kudva, Brenda Tromp, Rian Van Rampelbergh, Huiling Pei, Susan Wroblewski, Robin Carson, Maria Delioukina and Darrell White in Journal of Oncology Pharmacy Practice